MNST
Monster Beverage Corporation
MNST's fundamentals are strong: revenue grew 20% and it turned 20% of its revenue into free cash flow. At 41x earnings, it's trading in line with its usual 38x. Analysts expect earnings growth.
MNST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MNST's revenue, profitability, cash flow and balance sheet are all currently healthy.
MNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $35.43 | -22% |
| Forward | 36x | $45.57 | — |
| Fair | 38x | $41.36 | -9.2% |
| Current | 41x | $45.57 | — |
| Expensive | 43x | $47.63 | +4.5% |
Historical ranges are pointers, not guarantees.
MNST's PE is in its expensive range at 41x. If earnings grow as analysts expect, today's price would be 36x next year's earnings, in its fair range.
MNST Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MNST, with profitability holding steady.
MNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.26 | +15% |
| Q3 2026 | $1.10 | +25% |
| Q2 2026 | $1.08 | +33% |
| Q1 2026 | $1.03 | +36% |
| Q4 2025 | $0.97 | +31% |
| Q3 2025 | $0.88 | +13% |
| Q2 2025 | $0.81 | +1.2% |
| Q1 2025 | $0.76 | -3.8% |
| Q4 2024 | $0.74 | -3.9% |
MNST earned $1.10 per share over the past year, up 25% from the year before.
MNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +17% |
| Q2 2026 | $2.5B | +20% |
| Q1 2026 | $2.4B | +27% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $2.2B | +17% |
| Q2 2025 | $2.1B | +11% |
| Q1 2025 | $1.9B | -2.3% |
| Q4 2024 | $1.8B | +4.7% |
MNST's revenue has grown year over year for six quarters in a row: $2.6B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -2.7 points |
| Q2 2026 | 29% | -0.7 points |
| Q1 2026 | 31% | +0.3 points |
| Q4 2025 | 25% | +4.4 points |
| Q3 2025 | 31% | +5.2 points |
| Q2 2025 | 30% | +2.2 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 21% | -4 points |
MNST's operating margin was 28% last quarter, down 2.7 points from the same quarter a year ago.
MNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $525M | -25% |
| Q2 2026 | $460.8M | +6% |
| Q1 2026 | $584.4M | +22% |
| Q4 2025 | $351.2M | -5.2% |
| Q3 2025 | $701.5M | +23% |
| Q2 2025 | $434.6M | +15% |
| Q1 2025 | $478.5M | +38% |
| Q4 2024 | $370.4M | +15% |
MNST generated $1.9B in free cash flow over the past year, down 3.2% from the year before.
MNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.5% | +10.2M shares |
| 3 years | -6.6% | -140M shares |
| 5 years | -7.6% | -164M shares |
| Available history | -9.4% | -206M shares |
MNST has 2B diluted shares, up 0.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.4M |
| Q2 2026 | $8,000 |
| Q1 2026 | $134M |
| Q4 2025 | $59.7M |
| Q3 2025 | $27.3M |
| Q2 2025 | — |
| Q1 2025 | $16.6M |
| Q4 2024 | $1.7M |
MNST spent $294M buying back its own shares over the past year, about six times what it spent the year before.
MNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
| Q2 2024 | -0.4x | Net Cash |
| Q1 2024 | -1.2x | Net Cash |
MNST has more cash than debt.
MNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 60.6 | Neutral |
MNST's weekly RSI is 53 (neutral) and its Stochastic is 61 (neutral).
MNST PE vs Consumer Defensive Sector
| Metric | MNST | Sector median | Relative |
|---|---|---|---|
| PE | 41x | 19x | 112% above |
| PE % | 74 | 18 | 56 pts above |
MNST is trading at 41x earnings, a 112% premium to the Consumer Defensive sector's median of 19x.
MNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.0 | 1.2% above |
| 20 week MA | $46.0 | 0.9% below |
| 50 week MA | $42.7 | 6.8% above |
| 100 week MA | $36.4 | 25% above |
| 200 week MA | $31.7 | 44% above |
MNST's trend is mixed: it's above four of its five weekly moving averages, and 44% above its 200-week average.
MNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $22.5 | +41% |
| 2021 | $22.5 | $23.5 | +4.5% |
| 2022 | $23.5 | $25.3 | +7.9% |
| 2023 | $25.3 | $28.8 | +14% |
| 2024 | $28.8 | $26.3 | -8.8% |
| 2025 | $26.3 | $38.7 | +47% |
| 2026 YTD | $38.7 | $45.6 | +18% |
MNST has finished higher in five of the last six years. It's up 18% so far in 2026.